TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership Team
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
TRxADE Health, Inc. Announces Special Cash Dividend
TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
TRxADE Health, Inc. Announces Special Cash Dividend

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.